Talk:COVID-19 vaccine

This is the talk page for discussing improvements to the COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1, 2, 3, 4, 5: 30 days

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic.

Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

WikiProject COVID-19 consensus

WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.

General

Superseded by TfD October 2020 and later practice - consult regular {{Current}} guidance.

Refrain from using Worldometer (worldometers.info) as a source due to common errors being observed as noted on the Case Count Task Force common errors page. (April 2020, April 2020)

For infoboxes on the main articles of countries, use Wuhan, Hubei, China for the origin parameter. (March 2020)

"Social distancing" is generally preferred over "physical distancing". (April 2020, May 2020)

Page title

COVID-19 (full caps) is preferable in the body of all articles, and in the title of all articles/category pages/etc.(RM April 2020, including the main article itself, RM March 2021).

SARS-CoV-2 (exact capitalisation and punctuation) is the common name of the virus and should be used for the main article's title, as well as in the body of all articles, and in the title of all other articles/category pages/etc. (June 2022, overturning April 2020)

Map

There is no consensus about which color schemes to use, but they should be consistent within articles as much as possible. There is agreement that there should be six levels of shading, plus gray for areas with no instances or no data. (May 2020)

There is no consensus about whether the legend, the date, and other elements should appear in the map image itself. (May 2020)

For map legends, ranges should use fixed round numbers (as opposed to updating dynamically). There is no consensus on what base population to use for per capita maps. (May 2020)

To ensure you are viewing the current list, you may wish to purge this page.

COVID-19 Top‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
Top	This article has been rated as Top-importance on the project's importance scale.

Disaster management Top‑importance

	This article is within the scope of WikiProject Disaster management, a collaborative effort to improve the coverage of Disaster management on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Disaster managementWikipedia:WikiProject Disaster managementTemplate:WikiProject Disaster managementDisaster management articles
Top	This article has been rated as Top-importance on the project's importance scale.

Pharmacology Top‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Top	This article has been rated as Top-importance on the project's importance scale.

Medicine: Emergency / Pulmonology Top‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Top	This article has been rated as Top-importance on the project's importance scale.
	This article is supported by the Emergency medicine and EMS task force (assessed as Top-importance).
	This article is supported by the Pulmonology task force (assessed as Top-importance).

Viruses Top‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
Top	This article has been rated as Top-importance on the project's importance scale.

Section sizes

Section size for COVID-19 vaccine (41 sections)
Section name	Byte count	Section total
(Top)	13,528	13,528
Background	13,066	13,066
Vaccine technologies	6,999	41,293
mRNA vaccines	7,865	7,865
Adenovirus vector vaccines	7,159	7,159
Inactivated virus vaccines	5,646	5,646
Subunit vaccines	6,869	6,869
Virus-like particle vaccines	640	640
Other types	6,115	6,115
List of authorized vaccines	4,780	4,780
Delivery methods	188	6,292
Intranasal	4,284	4,284
Autologous	1,820	1,820
Universal vaccine	3,705	3,705
Formulation	1,769	1,769
Planning and development	1,594	21,667
Challenges	10,513	10,513
Organizations	9,560	9,560
Clinical research	139	337
Post-vaccination complications	198	198
History	866	866
Effectiveness	896	11,761
Duration of immunity	4,707	8,884
Immune evasion by variants	4,042	4,177
Vaccine adjustments	135	135
Effectiveness against transmission	961	961
Mix and match	1,020	1,020
Adverse events	18,443	18,443
Society and culture	26	52,166
Distribution	1,647	1,647
Access	35,996	39,720
Economics	3,724	3,724
Liability	8,313	8,313
Controversy	1,387	1,387
Misinformation and hesitancy	1,073	1,073
See also	249	249
Notes	36	36
References	33	33
Further reading	1,952	4,194
Vaccine protocols	2,242	2,242
External links	2,088	2,088
Total	196,273	196,273

Daily pageviews of this article

A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org

Page notices, consensus, and readership

Text and/or other creative content from this version of COVID-19 vaccine was copied or moved into COVID-19 vaccine clinical research with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

This article has previously been nominated to be moved.

Discussions:

No consensus, 11 March 2020, from COVID-19 vaccine to Coronavirus disease 2019 vaccine research, see discussion.
No consensus, 13 April 2020, from COVID-19 vaccine to COVID-19 vaccine development, see discussion.

Updated Advice Needs Updating[edit]

"In April 2021, Astrazeneca and the European Medicines Agency (EMA) updated their information for healthcare professionals about AZD1222."

Given this, could the article expand on what was meant by "causal relationship" between the vaccination and the occurrence of thrombosis? For even if the adverse reactions where said to be "very rare", by how much had they "exceeded what would be expected in the general population"? Also, could the EMA Statement be updated to include their last advice on vaccination and any risk of thrombosis? — Preceding unsigned comment added by 95.149.166.237 (talk) 20:11, 19 November 2023 (UTC)[reply]

EMA stated in writing, as do the manufacturers, that the vaccines do not, and were never intended to, stop or reduce transmission. The article should be edited to be truthful 85.94.248.27 (talk) 20:19, 11 January 2024 (UTC)[reply]

Discussion of a questionable (now retracted) study suggesting "dangers of mRNA vaccines"[edit]

Sadly discovered this posted by a relative who doesn't like the vaccine, but it is concerning.[1] Doug Weller talk 10:03, 29 January 2024 (UTC)[reply]

Junk, non-peer-reviewed journal and a rogues' gallery of contributors. Some sane commentary on it here.[2] Bon courage (talk) 10:07, 29 January 2024 (UTC)[reply]

My browser showed me this[3]. Doug Weller talk 11:42, 29 January 2024 (UTC)[reply]

Published by Cureus, a definite red flag. @Bon courage seeing this [4] RSN? Doug Weller talk 13:56, 29 January 2024 (UTC)[reply]

MDPI journals already listed at WP:RSP. Myself, I would probably never use this journal for health claims. Bon courage (talk) 13:58, 29 January 2024 (UTC)[reply]

How is that MDPI? Anyway, going to RSN now. Doug Weller talk 14:10, 29 January 2024 (UTC)[reply]

O yes, it's not MDPI. It's Springer Nature (?!). Bon courage (talk) 14:15, 29 January 2024 (UTC)[reply]

same people, same argument, different publisher.[5] Doug Weller talk 14:57, 29 January 2024 (UTC)[reply]

Just to cap this off: Cureus (unusually) retracted the article.[6] Bon courage (talk) 13:15, 20 February 2024 (UTC)[reply]
- I am surprised that a reasonably seasoned editor would have fallen for this bogus report in the first place. BD2412 T 16:43, 20 February 2024 (UTC)[reply]

Semi-protected edit request on 3 April 2024[edit]

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

In the end of the section "Adverse Events", after the part with tinnitus, the following references could be added, showing no signs of an increased rate of lasting vestibular damage:

https://doi.org/10.1111/ene.15546 https://doi.org/10.1097/mao.0000000000003275

It could read like this: "Compared to pre-pandemic cohorts, no increased rate of lasting peripheral-vestibular damage has been shown in observational studies [ref 1, 2]." J.Q.G. (talk) 07:42, 3 April 2024 (UTC)[reply]

Not done Would need secondary sourcing per WP:MEDRS. Bon courage (talk) 07:43, 3 April 2024 (UTC)[reply]